Autopsy report · NCT02152514

RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo

“Due to technical details recruitment was unreasonably slow”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month after it had already started.
• Ran for about 2 years 1 month before it stopped.
• 34 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Université de Sherbrooke

Sponsor type

University, hospital or other

Conditions

Thoracic Surgery, Video-assisted; Postoperative Pain; Rachianesthesia; Sufentanil; Morphine

Interventions

Intrathecal Morphine/Sufentanil; PCA

Participants

34

Sites

1

Countries

Canada

Trials that died the same way

• Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases
  “Very slow recruitment” (80% match in meaning)
• Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Burns
  “Much slower recruitment than anticipated” (79% match in meaning)
• Optimizing Clinical Outcomes in Patients Undergoing Mitral Transcatheter Edge-to-edge Repair (M-TEER) for Severe Functional Mitral Regurgitation Towards Improved Guideline-directed Medical Therapy
  “Recruitment too slow” (79% match in meaning)
• A Study of a Melatonin Receptor Agonist to Prevent Migraine
  “Recruitment slow and administrative reasons” (79% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (79% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.